Novartis Oncology Art Director Salary | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Art Director Salary

The average Novartis Oncology Art Director earns an estimated $122,636 annually. Novartis Oncology's Art Director compensation is $25,209 more than the US average for a Art Director.

The Design Department at Novartis Oncology earns $483 more on average than the Operations Department.

Last updated 3 years ago.

$27k
$48k
$69k
$90k
$232k
$489k
$505k
$122,636
Average Compensation
$122,636
avg. base

Art Director Salaries at Novartis Oncology

Art Directors earn $734 more than Senior Designers, and $14,863 less than Senior UI/UX Designers.

Principal Designer
$191k*
Creative Director
$161k*
Senior UI/UX Designer
$137k*
Senior Designer
$122k*
UI/UX Designer
$119k*
Web/Visual Designer
$102k*
Designer
$99k*
Graphic Designer
$78k*
Jr Designer
$67k*
* estimated salary

Compensation at Novartis Oncology by Department

The Design Department averages $483 more than the Operations Department, and $4,447 less than the Marketing Department

Marketing
$95,493 Avg. total comp.
+$4k
Design
$91,046 Avg. total comp.
Operations
$90,563 Avg. total comp.
-$483

Art Director Compensation by Gender (All Companies)

The average female Art Director at companies similar size to Novartis Oncology reported making $121,339, while the average male Art Director at similar sized companies reported making $127,685.

Art Director Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Art Director at companies similar size to Novartis Oncology reported making $160,000, while the average African American/Black Art Director at similar sized companies reported making $98,000.

How Art Directors at Novartis Oncology Rate Their Compensation

The majority of Art Directors at Novartis Oncology believe they're not compensated fairly. 100% of Art Directors at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company